Treatment of hepatocellular carcinoma with adriamycin. Preliminary communication.

  title={Treatment of hepatocellular carcinoma with adriamycin. Preliminary communication.},
  author={Charles L M Olweny and Taishu Toya and Edward Katongole-Mbidde and Jude A Mugerwa and S. K. Kyalwazi and Henry Cohen},
  volume={36 4},
In a Phase II clinical trial, 14 patients with histologically proven primary hepatocellular carcinoma were treated with adriamycin administered intravenously at a dose of 75 mg/m2 every 3 weeks. All 11 evaluable patients responded with 3 exhibiting complete tumor regression after two, three, and five courses of adriamycin respectively. The remission durations for these 3 were 3, 6, and 7 months, and their survivals were 8, 9, and 13 months, respectively. The median survival of the evaluable… CONTINUE READING

From This Paper

Topics from this paper.
25 Citations
0 References
Similar Papers


Publications citing this paper.
Showing 1-10 of 25 extracted citations

Similar Papers

Loading similar papers…